Clinical Trials Logo

Clinical Trial Summary

The aim of the study was to analyze which step of the procedure of toxin botulinum injection is the most painful between skin break-in, electric stimulation, injection and needle withdrawal.


Clinical Trial Description

Post-stroke spasticity management by botulinum toxin injections may be limited by pain or discomfort at the injection side.

Particularly tracking by electrostimulation, but also skin puncture, toxin injection or needle withdrawal may be painful.

The objective of this study is to define an individual injection strategy in order to limit pain. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03251521
Study type Observational
Source University Hospital, Grenoble
Contact
Status Completed
Phase N/A
Start date March 2012
Completion date July 2013

See also
  Status Clinical Trial Phase
Completed NCT00460564 - Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity Phase 3
Completed NCT00460655 - Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity Phase 3
Completed NCT01251367 - Dysport® Adult Lower Limb Spasticity Follow-on Study Phase 3